MBIO
MUSTANG BIO, INC.
Key Financials
Net Income
$-1921000
↑ 87.8%
Operating Income
$-2432000
↑ 85.0%
Revenue
$0
NaN%
EPS (Diluted)
$-0.39
↑ 99.0%
Total Assets
$17.6M
↑ 89.0%
Shareholders' Equity
$9.5M
↑ 346.0%
Total Liabilities
$8.1M
↓ 38.8%
Cash & Equivalents
$17.3M
↑ 152.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/17/2026 | View on SEC |
| 10-K | 3/19/2026 | View on SEC |
| SCHEDULE 13D/A | 1/5/2026 | View on SEC |
| 4 | 1/5/2026 | View on SEC |
| 4 | 12/30/2025 | View on SEC |
| 4 | 12/30/2025 | View on SEC |
| 4 | 12/30/2025 | View on SEC |
| 8-K | 12/23/2025 | View on SEC |
| DEF 14A | 12/3/2025 | View on SEC |
| 10-Q | 11/7/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MBIO |
| Company Name | MUSTANG BIO, INC. |
| CIK | 1680048 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 7816524500 |